HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,022 | +8.8% | 17,476 | -3.2% | 0.01% | +16.7% |
Q2 2023 | $1,858 | -7.1% | 18,063 | -1.4% | 0.01% | -14.3% |
Q1 2023 | $1,999 | -1.7% | 18,313 | +2.5% | 0.01% | -12.5% |
Q4 2022 | $2,033 | -99.8% | 17,868 | +4.8% | 0.02% | +77.8% |
Q3 2022 | $1,055,000 | -21.5% | 17,043 | +1.1% | 0.01% | -10.0% |
Q2 2022 | $1,344,000 | -21.2% | 16,850 | +3.9% | 0.01% | -9.1% |
Q1 2022 | $1,705,000 | +1.9% | 16,210 | +4.3% | 0.01% | +10.0% |
Q4 2021 | $1,674,000 | -0.7% | 15,539 | +0.9% | 0.01% | -9.1% |
Q3 2021 | $1,686,000 | +19.1% | 15,394 | +1.8% | 0.01% | +10.0% |
Q2 2021 | $1,416,000 | +5.5% | 15,127 | +3.7% | 0.01% | 0.0% |
Q1 2021 | $1,342,000 | +97.9% | 14,582 | +57.4% | 0.01% | +100.0% |
Q4 2020 | $678,000 | +606.2% | 9,262 | +649.4% | 0.01% | +400.0% |
Q3 2020 | $96,000 | +200.0% | 1,236 | +16.9% | 0.00% | 0.0% |
Q2 2020 | $32,000 | +3.2% | 1,057 | 0.0% | 0.00% | – |
Q1 2020 | $31,000 | -18.4% | 1,057 | 0.0% | 0.00% | – |
Q4 2019 | $38,000 | +18.8% | 1,057 | -11.0% | 0.00% | – |
Q3 2019 | $32,000 | +14.3% | 1,188 | +2.1% | 0.00% | – |
Q2 2019 | $28,000 | – | 1,163 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |